WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 28, 2004, 24(30):6799-6809; doi:10.1523/JNEUROSCI.5463-03.2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tong, L.
Right arrow Articles by Cotman, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tong, L.
Right arrow Articles by Cotman, C. W.

 Previous Article  |  Next Article 

Cellular/Molecular
{beta}-Amyloid Peptide at Sublethal Concentrations Downregulates Brain-Derived Neurotrophic Factor Functions in Cultured Cortical Neurons

Liqi Tong, Robert Balazs, Phillip L. Thornton, and Carl W. Cotman

Institute for Brain Aging and Dementia, University of California Irvine, Irvine, California 92697-4540

The accumulation of {beta}-amyloid (A{beta}) is one of the etiological factors in Alzheimer's disease (AD). It has been assumed that the underlying mechanism involves a critical role of A{beta}-induced neurodegeneration. However, low levels of A{beta}, such as will accumulate during the course of the disease, may interfere with neuronal function via mechanisms other than those involving neurodegeneration. We have been testing, therefore, the hypothesis that A{beta} at levels insufficient to cause degeneration (sublethal) may interfere with critical signal transduction processes. In cultured cortical neurons A{beta} at sublethal concentrations interferes with the brain-derived neurotrophic factor (BDNF)-induced activation of the Ras-mitogen-activated protein kinase/extracellular signal-regulated protein kinase (ERK) and phosphatidylinositol 3-kinase (PI3-K)/Akt pathways. The effect of sublethal A{beta}1-42 on BDNF signaling results in the suppression of the activation of critical transcription factor cAMP response element-binding protein and Elk-1 and cAMP response element-mediated and serum response element-mediated transcription. The site of interference with the Ras/ERK and PI3-K/Akt signaling is downstream of the TrkB receptor and involves docking proteins insulin receptor substrate-1 and Shc, which convey receptor activation to the downstream effectors. The functional consequences of A{beta} interference with signaling are robust, causing increased vulnerability of neurons, abrogating BDNF protection against DNA damage- and trophic deprivation-induced apoptosis. These new findings suggest that A{beta} engenders a dysfunctional encoding state in neurons and may initiate and/or contribute to cognitive deficit at an early stage of AD before or along with neuronal degeneration.

Key words: {beta}-amyloid; BDNF; CREB; MAPK; cortical neurons; PI3-K


Received Dec 12, 2003; revised April 9, 2004; accepted April 30, 2004.




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
H.-K. Lee, P. Kumar, Q. Fu, K. M. Rosen, and H. W. Querfurth
The Insulin/Akt Signaling Pathway Is Targeted by Intracellular {beta}-Amyloid
Mol. Biol. Cell, March 1, 2009; 20(5): 1533 - 1544.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
J. Gunstad, A. Benitez, J. Smith, E. Glickman, M. B. Spitznagel, T. Alexander, J. Juvancic-Heltzel, and L. Murray
Serum Brain-Derived Neurotrophic Factor Is Associated With Cognitive Function in Healthy Older Adults
J Geriatr Psychiatry Neurol, September 1, 2008; 21(3): 166 - 170.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
E. Sturchler, A. Galichet, M. Weibel, E. Leclerc, and C. W. Heizmann
Site-Specific Blockade of RAGE-Vd Prevents Amyloid-{beta} Oligomer Neurotoxicity
J. Neurosci., May 14, 2008; 28(20): 5149 - 5158.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Petratos, Q.-X. Li, A. J. George, X. Hou, M. L. Kerr, S. E. Unabia, I. Hatzinisiriou, D. Maksel, M.-I. Aguilar, and D. H. Small
The -amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism
Brain, January 1, 2008; 131(1): 90 - 108.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. J. Garzon and M. Fahnestock
Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma Cells
J. Neurosci., March 7, 2007; 27(10): 2628 - 2635.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Chow, R. D. Bell, R. Deane, J. W. Streb, J. Chen, A. Brooks, W. Van Nostrand, J. M. Miano, and B. V. Zlokovic
Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype
PNAS, January 16, 2007; 104(3): 823 - 828.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-